HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

fibrinmonomer

converted from fibrinogen by thrombin action
Also Known As:
fibrin monomer; fibrin monomer complexes
Networked: 192 relevant articles (2 outcomes, 16 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Takeishi, Yasuchika: 3 articles (02/2021 - 08/2006)
2. Wada, Hideo: 3 articles (09/2012 - 01/2003)
3. Momot, A P: 2 articles (12/2020 - 03/2011)
4. Belagaje, Samir: 2 articles (01/2020 - 12/2018)
5. Belair, Trina: 2 articles (01/2020 - 12/2018)
6. Bianchi, Nicolas: 2 articles (01/2020 - 12/2018)
7. Duncan, Alexander: 2 articles (01/2020 - 12/2018)
8. Henriquez, Laura: 2 articles (01/2020 - 12/2018)
9. Hoskins, Michael: 2 articles (01/2020 - 12/2018)
10. Nahab, Fadi: 2 articles (01/2020 - 12/2018)

Related Diseases

1. Hemorrhage
07/01/2005 - "Fibrin monomer should be further investigated for it's potential to serve as a routine tool for preoperative risk stratification of intraoperative bleeding."
09/01/1974 - "All 3 patients receiving heparin showed clinical cessation of abnormal bleeding and disappearance of soluble fibrin monomer complexes within 24 hours of starting therapy. "
01/01/1991 - "To control the efficacy of PCT, its individualization, intensity and duration, it is recommended that in addition to the common tests, the activity of the antithrombin-III-heparin complex may be measured and the test for the presence of fibrin monomer in the plasma be made, since these parameters clearly reflect the changes in the system of hemostasis and enable one to discover the early signs of proliferation activation in MM thereby preventing hemorrhages."
12/26/2020 - "The presence of DIC is substantiated by the morphological picture of changes in organs and tissues, clinical (hematoma-petechial type of bleeding in combination with thromboembolic syndrome and the presence of thrombovasculitis) and laboratory changes: an increase in the level of soluble fibrin-monomer complexes, D-dimer, hyperfibrinogenaemia, less often - thrombocytopenia, violation of fibrinolytic activity. "
01/01/1981 - "It appears that the diagnostic tests most likely to aid in diagnosis and to reliably inform the clinician when the intravascular clotting process has been stopped are those that determine the antithrombin-III level, the presence of soluble fibrin monomer, and the finding of elevated fibrin(ogen) degradation products, thrombocytopenia and a prolonged thrombin time in the face of the appropriate type of bleeding in the appropriate clinical setting. "
2. Aortic Dissection
3. Myocardial Infarction
4. Thrombosis (Thrombus)
5. Disseminated Intravascular Coagulation

Related Drugs and Biologics

1. Antithrombin III
2. Heparin (Liquaemin)
3. fibrin fragment D (D-dimer)
4. Fibrinogen (Factor I)
5. antithrombin III-protease complex
6. Prothrombin (Factor II)
7. Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)
8. Fibrinolysin
9. Dalteparin (Dalteparin Sodium)
10. Fibrin

Related Therapies and Procedures

1. Drug Therapy (Chemotherapy)
2. Euthanasia (Mercy Killing)
3. Therapeutics
4. Knee Replacement Arthroplasty (Total Knee Replacement)
5. Herniorrhaphy